Southern Research

We are on the ground at the Society of Toxicology Annual Meeting and ready to connect! Our team is showcasing the latest advancements in toxicology and drug development. ? Come visit Booth #851 to learn about our latest research and capabilities, explore partnership opportunities, and discuss how we can collaborate to drive scientific breakthroughs.

We are excited to attend the Society of Toxicology (SOT) Annual Meeting & ToxExpo from March 16-20 in Orlando, Florida. This event brings together leading experts in toxicology, and we look forward to connecting, sharing insights, and exploring the latest advancements in the field. ? Make plans to visit us at Booth #851 to meet our team, learn about our research, and discuss how we can collaborate. Whether you're looking for innovative solutions or want to chat, we'd love to connect!

We enjoyed sharing the construction progress on our new research building with Innovate Alabama leaders and touring our state-of-the-art Station 41 Incubator facility. We’re grateful to Innovate Alabama for their support of our Station 41 Therapeutics Development Fund through the Innovate Alabama Tax Credit Program, which is fueling the development of life-saving therapeutics and the growth of Alabama’s biotechnology industry by providing in-kind scientific services and entrepreneurial support to biotechnology startups.

Since breaking ground in the summer of 2022, we've been eagerly anticipating the opening of our new state-of-the-art facility—set to open in July 2025! ? This 135,000-square-foot high-rise addition will feature four floors of wet labs and offices designed to extend our research capabilities, enable new initiatives, and support continued expansion. It will be a welcome addition to our campus, first established 80 years ago, and continues to demonstrate our commitment to growth, progress, and a brighter future.

We are proud to have Dr. Brian Gibbs as Investor-in-Residence in our incubator, Station 41. With his impressive background in evaluating and scaling biotech innovations, Dr. Gibbs will offer critical guidance to our residents, helping them connect with key investors and secure strategic partnerships.

Congratulations to the residents of Station 41, and welcome to Dr. Bruce Jones. We are excited to see his hands-on mentorship empower our community.?

We are proud to be a driving force in Alabama's tech and biotech ecosystem. Learn how we're fostering innovation and supporting the growth of this exciting sector. https://lnkd.in/eQBHQNE4

This $44 million grant will revolutionize the Birmingham Biotechnology Hub. Learn how this investment will accelerate drug development, create jobs, and improve healthcare access for all Alabamians. https://lnkd.in/gKSmueYA?

We are very excited to share that the U.S. Economic Development Administration has awarded the Birmingham Biotechnology Hub $44M across five projects! This is a outstanding team win for many partner organizations across Birmingham and the state of Alabama. The federal grant funding will be integral to driving our city’s biotech economy forward and increasing diverse representation in clinical genomic data and clinical trials.

From our friends at Catalyst: We’re thrilled to share that Dr. Khalilah Brown, Chief Medical Officer at Southern Research, has been named to the Board of Director of the Alabama School of Healthcare Sciences Foundation. As the leader of Catalyst by Southern Research, Dr. Brown is committed of providing access to genomic sequencing and precision medicine throughout Alabama. Her dedication to addressing Alabama’s rural healthcare challenges and inspiring the next generation of healthcare leaders. Read more about it: https://lnkd.in/eQic9fDe